This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
EV-302
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher® Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Urologic Catheters (Includes CAUTI)
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Actionable Clinical Data
Bladder Cancer
LG-IR NMIBC
Adstiladrin®
Kidney Cancer
ZIRCON
Trials in Progress
Trials in Progress
Bladder Cancer
BOND-003 Cohort P
CORE-008
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
UCLA-UCSF-PCF PSMA 2025
EAU 2025
SES AUA 2025
Thought Leaders 2025
APCCC Diagnostics 2025
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Bladder Cancer
Conferences
Recent Abstracts
AUA 2018: Assessing the Under-Estimation of Nodal Tumour Burden by 68ga-PSMA and 11c-Choline PET/CT Scan in Patients Treated with Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer
May 19, 2018
AUA 2018: Radical Cystectomy Provides Improved Survival Outcomes and Decreased Costs Compared with Trimodal Therapy for Patients Diagnosed with Localized Muscle-Invasive Bladder Cancer
May 19, 2018
AUA 2018: Phase 3 Study of Intermittent Monotherapy Versus Continuous Combined Androgen Deprivation
May 19, 2018
AUA 2018: Comprehensive Characterization of Returns to the Operating Room following Radical Cystectomy
May 19, 2018
AUA 2018: Results from SPARTAN: PSA Outcomes in Patients with Nonmetastatic Castration-Resistant Prostate Cancer Treated with Apalutamide
May 18, 2018
AUA 2018: The PROSPER Trial: Chemotherapy-related Endpoints in Patients with Nonmetastatic Castration-resistant Prostate Cancer Treated with Enzalutamide
May 18, 2018
AUA 2018: Crossfire Debate: Controversies in Prostate Cancer (Con) – ADT plus Abiraterone is Key to Prolonging Survival in Oligometastatic Prostate Cancer
May 18, 2018
AUA 2018: A Crossfire Debate: Controversies in Prostate Cancer (Pro) – Focal Ablation of Oligometastatic Prostate Cancer
May 18, 2018
AUA 2018: Impact of Post-Treatment Psychiatric Illness on Survival Outcomes Following Treatment for Patients with Muscle-Invasive Bladder Cancer
May 18, 2018
AUA 2018: Perioperative Blood Transfusion is Not an Independent Predictor of Survival After Radical Cystectomy
May 18, 2018
AUA 2018: The Impact of Agent Orange Exposure on Bladder Cancer
May 18, 2018
AUA 2018: Tumor Board - Bladder Cancer: Treatment Algorithms for Localized Bladder Cancer
May 18, 2018
AUA 2018: Early versus Standard Catheter Removal After Complete Anatomical Reconstruction During Robot-Assisted Radical Prostatectomy: Results from RIPRECA
May 18, 2018
AUA 2018: Surgical Techniques: Tips & Tricks: Robotic Partial Nephrectomy
May 18, 2018
AUA 2018: Tumor Board - Kidney Cancer: The Current State of Knowledge and Management Paradigms for Patients with Kidney Cancer
May 18, 2018
AUA 2018: Clinical and Oncological Outcomes of Robot-Assisted Radical Prostatectomy with Nerve Sparing for High-Risk Prostate Cancer Patients
May 18, 2018
AUA 2018: Duration of PSA Surveillance after Radical Prostatectomy: A Risk Adapted Approach
May 18, 2018
AUA 2018: Should Gleason Score at the Positive Surgical Margin appear on the Pathology Report for Robot-Assisted Radical Prostatectomy?
May 18, 2018
AUA 2018: Predicting Perioperative Complications in Patients Receiving Radical Cystectomy Using Pre-Operative CT-Measured Adipose Tissue Indices
May 18, 2018
AUA 2018: Application of AUA Risk Stratification for NMIBC: Long-term Results in a Contemporary Single Institution Cohort
May 18, 2018
Page 417 of 614
Start
Prev
412
413
414
415
416
417
418
419
420
421
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free